Nutanix reported a strong Q4 and fiscal year 2023, with significant year-over-year growth in ACV billings and improvements in profitability and free cash flow. The board also authorized a $350 million stock repurchase program.
ACV Billings increased by 44% year-over-year to $278.7 million.
Annual Recurring Revenue (ARR) grew by 30% year-over-year to $1.56 billion.
Revenue increased by 28% year-over-year to $494.2 million.
Free cash flow was $45.5 million, compared to $23.2 million in the same quarter last year.
Nutanix provided its outlook for Q1 2024.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance